Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 01.07.2022.

#BioSpace
#BiopharmaCompanies
#BIO
#Arzeda
#CyrusBiotech
#OutpaceBio
#BiotechIndustry

@sangerinstitute shared
On Jun 28, 2022
RT @NatureBiotech: High-throughput total RNA sequencing in single cells using VASA-seq https://t.co/qHngVoP5N1 https://t.co/VDtBh2oHr6
Open
High-throughput total RNA sequencing in single cells using VASA-seq

High-throughput total RNA sequencing in single cells using VASA-seq

VASA-seq sequences total RNA in single cells, revealing non-coding expression and splicing patterns.

@biospace shared
On Jun 27, 2022
Small to mid-size biopharmaceutical companies are the lifeblood of the industry and some of those businesses are adding new blood to their rosters, even in uncertain times. #BiopharmaCompanies #BIO #BioSpace https://t.co/hmAuhjJ5wQ
Open
Small and Medium Biotech Companies Still Growing in Uncertain Times

Small and Medium Biotech Companies Still Growing in Uncertain Times

BioSpace spoke with three CEOs: Alto Neuroscience’s Dr. Amit Etkin, Omega Therapeutics’ Mahesh Karande and Rain Therapeutics’ Avanish Vellanki about their companies' employment growth.

@SynBioBeta shared
On Jun 29, 2022
This year's 35 Innovators in biotech are breaking new ground via machine learning, gene therapy, gene analysis, and CRISPR. https://t.co/amRqdhrPU1
Open
Rewriting what we thought was possible in biotech

Rewriting what we thought was possible in biotech

This year's 35 Innovators in biotech are breaking new ground via machine learning, gene therapy, gene analysis, and CRISPR.

@biospace shared
On Jun 28, 2022
Three biotech companies, @ArzedaCo, @cyrusbiotech and @OutpaceBio, are teaming up to use machine learning to optimize protein folding and design efforts. #Arzeda #CyrusBiotech #OutpaceBio #BioSpace https://t.co/So3N9hpKnE
Open
Biotech Companies Team Up to Design New Proteins with ML

Biotech Companies Team Up to Design New Proteins with ML

Arzeda, Cyrus Biotechnology and Outpace Bio, are teaming up to use machine learning and optimize protein folding and design efforts.

@SynBioBeta shared
On Jun 27, 2022
"The complexity of biology is cause for humility, but also enthusiasm. There is an opportunity in biotechnology to learn and even harness processes and abilities that no one could never invent, let alone fully understand." @ebenbayer https://t.co/XUw3zYvmDQ
Open
Biotech Says It Can Program Life To Make New Stuff. Is That True?

Biotech Says It Can Program Life To Make New Stuff. Is That True?

Biotechnology has matured to the point where scientists increasingly regard living cells as programmable, but not everyone agrees with using that term.

@JohnCendpts shared
On Jun 29, 2022
Biotech's high-stake gambler: As bear market continues to beat down biotech, ARCH closes a $3B early-stage fund https://t.co/1IQyaLhxFx
Open
As bear market continues to beat down biotech, ARCH closes a $3B early-stage fund

As bear market continues to beat down biotech, ARCH closes a $3B early-stage fund

One of the biggest names in biotech investing has a whole lot of new money to spend. ARCH Venture Partners closed its 12th venture fund early Wednesday morning, the firm said, bringing in ...

@JohnCendpts shared
On Jun 30, 2022
Scoop: A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders, guts CMC https://t.co/6YzP26z33Q
Open
Scoop: A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders, guts CMC

Scoop: A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders, guts CMC

En route to entering the clinic with its first AAV-based gene therapy for a rare neuromuscular disease, AavantiBio has let go of 30 employees, Endpoints News has learned. The move comes ...

@biospace shared
On Jun 30, 2022
Battered by a struggling stock market and inflation, the biotech industry has been looking for multiple sources of financing, including the potential sale of net operating loss carryforwards. #BiotechIndustry #BioSpace https://t.co/bVJGfOE0Jh
Open
Big Pharma not Likely to Bail Out Battered Biotech Industry

Big Pharma not Likely to Bail Out Battered Biotech Industry

The biotech industry has been looking for multiple sources of financing, and there has been speculation that big pharma might come to the rescue. But a recent report says that's unlikely.